Hamilton Morris

Hamilton Morris, a chemist and filmmaker renowned for "Hamilton's Pharmacopeia," teams up with Dr. Mark Plotkin, an ethnobotanist and president of the Amazon Conservation Team. Together, they delve into the rich history of psychoactive substances, debating the merits of synthetic versus natural options. They explore microdosing, the mysteries of 5-MeO-DMT, and the ecological implications of interest in the Sonoran Desert Toad. Morris and Plotkin emphasize the importance of open dialogue in both conservation and psychedelic research, while reflecting on Timothy Leary's lasting influence.

Hamilton Morris, a journalist and creator of 'Hamilton's Pharmacopeia,' dives deep into the world of psychedelics and drug culture. He discusses DARPA's psychedelic research aimed at treating PTSD and the intriguing use of toad venom as a natural vaccine. The conversation takes a sharp turn as Morris reflects on VICE's downfall and explores the complexities of addiction, contrasting kratom with opioids. Listeners will enjoy his insights on the social constructs of drug perception and the emerging controversies in psychedelic research.

Chris Glenn shares his personal journey with Kratom and Tianeptine addiction, highlighting the emotional struggles linked to dependency. Oliver Gruntman, a clinical expert, discusses the safety concerns and market risks surrounding Kratom's unregulated use. Hamilton Morris provides insights into the misconceptions about Tianeptine, stressing its addictive qualities and regulatory challenges. Together, they explore the evolving American drug culture, the need for better consumer education, and the vital role of pharmacists in public health.

Hamilton Morris, creator and host of "Hamilton's Pharmacopeia," dives into the fascinating world of psychedelics and their therapeutic potential. He discusses the complexities of psychedelic research, funding hurdles, and the shifting public perceptions surrounding substances like psilocybin and LSD. The conversation also touches on the societal stigma of drug use, advocating for compassion and understanding. Additionally, Morris explores the role of personal autonomy in substance consumption and critiques the paradox of regulations around personal enjoyment, like music and tobacco.

Hamilton Morris, a chemist, journalist, and documentary filmmaker, delves into the intricate world of psychoactive substances. He critiques the media's portrayal of fentanyl and discusses the politicization of addiction. The conversation also touches on the complexities of vaping and societal perceptions that shape drug narratives. Morris shares his journey from chemistry to documentary filmmaking, exploring challenges in drug policy and the influence of corporate interests on distribution. The light-hearted talks about the 'Philadelphia Nitrous Mafia' add humor to the insightful dialogue.

Hamilton Morris, a chemist and filmmaker known for exploring psychedelics, dives deep into the transformative world of psychoactive substances. He discusses the therapeutic potential of iboga for addiction, sharing personal rituals from Central West Africa. The conversation also explores the cultural dynamics of psychedelics, the ethical sourcing of these substances, and the significance of ritual in psychedelic experiences. Morris highlights the ongoing evolution in drug research and the importance of responsible practices in this intriguing field.

A LIVE DTFH recorded at the Bell House in Brooklyn with Hamilton Morris (Hamilton's Pharmacopia, VICE) and Emil Amos (Holy Sons, OM).

Hamilton Morris, a renowned chemist, filmmaker, and journalist, dives into the crucial issues surrounding the DEA's attempts to classify DOI and DOC as Schedule I substances. He shares his firsthand experiences from a DEA hearing, exposing the bureaucratic mess that stifles psychedelic research. Morris discusses the safety profiles of these compounds, the frustrating exclusion of expert testimonials in court, and the environmental concerns tied to Sonoran Desert toad venom use. This eye-opening conversation emphasizes the pressing need for improved drug policy and advocacy for scientific progress.

Hamilton Morris, a prominent journalist and scientist known for his exploration of psychedelics in "Hamilton's Pharmacopeia," joins to unravel the shocking truth behind the FDA’s rejection of MDMA-assisted therapy. He reveals a covert agenda aimed at blocking this revolutionary treatment, highlighting the intertwining of politics, capitalism, and misinformation. The conversation dives into the misconceptions about safety concerns and the suppression of potentially life-changing therapies, emphasizing the urgent need for a reevaluation of how society approaches mental health solutions.

Hamilton Morris, a psychedelic journalist and researcher, explores the history and effects of lesser-known compounds like bufotenin. He shares insights from his work on Hamilton's Pharmacopeia and discusses the limitations of reductionist approaches to understanding psychedelics. The podcast also touches on the importance of a balanced perspective in psychedelic journalism and references influential figures such as Alexander Shulgin and Terrence McKenna.